Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine HCG in Repeated Implantation Failure
NCT03682614Completed
- Sponsor
- Reproductive and Genetic Hospital of CITIC-Xiangya
- Start
- Dec 2018
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of human chorionic gonadotropin in Repeated Implantation Failure (RIF), sponsored by Reproductive and Genetic Hospital of CITIC-Xiangya. Primary endpoint: clinical pregnancy rate. Started Dec 2018; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
Repeated Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT03682614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03682614.